Fundamental analysis by اسمارت بورس about Stock دبالک on 2/25/2021

#Dallek Production of Alborz Black Medicine Information and Financial Statements of the 9 -month period ending on 09/30/2019 (unchanged) ️ ️ Increased 102 % of operating revenues in 1399 compared to the same period from 583,909 million rials to 1,177,799 million rials. Increasing 116 % GDP 999 has increased from 208,295 million rials to 448,932 million rials compared to the same period. Increased 153 % of the 9 -month operational profit of 1399 compared to the same period from 144857 million rials to 3664443 million rials. Increased 251 % of the 9 -month net profit of 1399 and the realization of the profit of 675 rials per share from 71044 million rials to 249594 million rials. 2. Operational profit margin increased from 24.81% to 31.11% and net loss (12.17%) increases from 12.17% to 21.19%. ️ ️ ️ 112 % increase in assets, 170 % increase in debt and 50 % increase of ownership salaries from 424,620 million rials to 637,214 million Rials The ratio of the debt increased from 51.27% to 65.46% and the current ratio decreased from 1.8 times to 1.45 times. @smart_investor ♌️